![Andrew Hamer](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Andrew Hamer
Chief Tech/Sci/R&D Officer at CARDIOL THERAPEUTICS INC.
Net worth: 627 176 $ as of 31/05/2024
Andrew Hamer active positions
Companies | Position | Start | End |
---|---|---|---|
CARDIOL THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 29/03/2021 | - |
Career history of Andrew Hamer
Former positions of Andrew Hamer
Companies | Position | Start | End |
---|---|---|---|
AMGEN INC. | Corporate Officer/Principal | 01/01/2018 | 01/03/2021 |
CAPRICOR THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 22/11/2013 | 30/07/2015 |
Capricor, Inc.
![]() Capricor, Inc. BiotechnologyHealth Technology Part of Capricor Therapeutics, Inc., Capricor, Inc. is a company that provides cardiac stem cell therapeutics biotechnology services. The company is based in Los Angeles, CA. The company was founded by Linda Marbán. Linda Marbán has been the CEO since incorporation. Capricor was acquired by Capricor Therapeutics, Inc. on November 21, 2013. | Chief Tech/Sci/R&D Officer | 01/11/2013 | - |
Training of Andrew Hamer
University of Otago | Undergraduate Degree |
Statistics
International
United States | 4 |
New Zealand | 2 |
Canada | 2 |
Operational
Chief Tech/Sci/R&D Officer | 3 |
Undergraduate Degree | 1 |
Corporate Officer/Principal | 1 |
Sectoral
Health Technology | 5 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 3 |
---|---|
CAPRICOR THERAPEUTICS, INC. | Health Technology |
CARDIOL THERAPEUTICS INC. | Health Technology |
AMGEN INC. | Health Technology |
Private companies | 1 |
---|---|
Capricor, Inc.
![]() Capricor, Inc. BiotechnologyHealth Technology Part of Capricor Therapeutics, Inc., Capricor, Inc. is a company that provides cardiac stem cell therapeutics biotechnology services. The company is based in Los Angeles, CA. The company was founded by Linda Marbán. Linda Marbán has been the CEO since incorporation. Capricor was acquired by Capricor Therapeutics, Inc. on November 21, 2013. | Health Technology |
- Stock Market
- Insiders
- Andrew Hamer
- Experience